Log in
SEARCH
All
News
CPD
CATEGORIES
Upcoming Events
Podcasts
On demand
Bone health
Gestational diabetes
Hormones
Medicines
Medicopolitical
Obesity
Public health
Research
Risk factors
Thyroid
Type 1 diabetes
Type 2 diabetes
About
About the limbic
Contact
Website Disclaimer
Privacy Policy
Terms & Conditions
news
cpd
Search
All
News
CPD
Account
Saved
SEARCH
All
News
CPD
CATEGORIES
Bone health
Gestational diabetes
Hormones
Medicines
Medicopolitical
Obesity
Public health
Research
Risk factors
Thyroid
Type 1 diabetes
Type 2 diabetes
Events
Podcasts
On demand
Log out
How to deliver ‘4 pillars’ of treatment in T2D and CKD
Type 2 diabetes
Bisphosphonate type matters for drug holidays
Bone health
Pharma funding: which specialties accept the most payments?
Financial
Why the pathology bulk-billing campaign is more about driving industry profits than saving you money
Financial
Hospital guidance needed on long-acting IDegAsp insulin
Type 2 diabetes
Aussie diabetes patients list their research priorities
Research
MORE NEWS
New guidelines for osteoporosis management in men
Bone health
Special report: leadership chaos strikes the RACP
Medical politics
Why medical indemnity is back on the agenda
Financial
Healthcare private equity acquisitions on the rise in Australia
Financial
SGLT2i listed for CKD regardless of T2D status
Medicines
Statins and diabetes risk: what’s the latest evidence?
Risk factors
ESA members ‘mostly follow’ thyroid hormone guidelines
Thyroid
Institute launches cultural probe amid sexual harassment claims
sexism
RACP boss resigns as college goes into the red
medical education
Urgent regulation needed on ‘risky’ medical AI
e-health
Identifying opioid tapering pathways to safely stop use
Pain
SGLT2i-related DKA overdiagnosis a problem for patients with T2D
Type 2 diabetes
more news